HFCL and Sterlite Technologies hit their upper circuits on Tuesday, extending their sharp 2026 rallies on strong business updates. HFCL has surged over 267% so far this year, while Sterlite Tech has delivered a staggering 705% return, making both standout multibaggers.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the